|
AU2013265307A1
|
|
Heterocyclyl pyrimidine analogues as TYK2 inhibitors
|
|
CN104169272A
|
|
Pyrimidine-2,4-diamine derivatives as kinase inhibitors
|
|
CN103946222A
|
|
Morpholino substituted bicyclic pyrimidine urea or carbamate derivatives as MTOR inhibitors
|
|
CN103917530A
|
|
Morpholino substituted urea or carbamate derivatives as MTOR inhibitors
|
|
KR20140063700A
|
|
Pyrazolo[4,3-c]pyridine derivatives as kinase inhibitors
|
|
WO2013017479A1
|
|
Pyrazolo[4,3-c]pyridine derivatives as jak inhibitors
|
|
WO2013017480A1
|
|
Pyrazolo[4,3-c]pyridine derivatives as jak inhibitors
|
|
CN103781780A
|
|
Heterocyclyl pyrimidine analogues as JAK inhibitors
|
|
ZA201202837B
|
|
Heterocyclyl pyrazolopyrimidine analogues as jak inhibitors
|
|
WO2012143320A1
|
|
(7h-pyrrolo[2,3-d]pyrimidin-2-yl)amine compounds as jak3 inhibitors
|
|
EP2694511A1
|
|
Dihydropyrrolo pyrimidine derivatives as mtor inhibitors
|
|
AU2011328237A1
|
|
Pyridine compounds and aza analogues thereof as TYK2 inhibitors
|
|
EP2606050A2
|
|
Heterocyclyl pyrazolopyrimidine analogues as selective jak inhibitors
|
|
WO2012022681A2
|
|
Heterocyclyl pyrazolopyrimidine analogues as selective jak inhibitors
|
|
EP2588105A1
|
|
Triazolopyridines as tyk2 inhibitors
|
|
SG184989A1
|
|
Pyrazole compounds as jak inhibitors
|
|
WO2011107585A1
|
|
Morpholino substituted urea derivatives as mtor inhibitors
|
|
KR20120102601A
|
|
Heterocyclyl pyrazolopyrimidine analogues as jak inhibitors
|
|
EP2475648A1
|
|
Ortho substituted pyrimidine compounds as jak inhibitors
|
|
CA2763730A1
|
|
Heterocyclylaminopyrimidines as kinase inhibitors
|
